Daymark Wealth Partners’s Boston Scientific BSX Stock Holding History

Daymark Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$596K	Buy	9,498 +3,810	+67%	+$305K	0.02%	376
2025 Q4	$542K	Buy	5,688 +717	+14%	+$70.3K	0.02%	373
2025 Q3	$485K	Buy	4,971 +151	+3%	+$15.6K	0.02%	388
2025 Q2	$518K	Buy	4,820 +961	+25%	+$97.2K	0.02%	346
2025 Q1	$389K	Sell	3,859 -122	-3%	-$12.3K	0.02%	367
2024 Q4	$356K	Buy	3,981 +627	+19%	+$55.2K	0.02%	381
2024 Q3	$281K	Buy	+3,354	New	+$264K	0.01%	435

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Daymark Wealth Partners's BSX Position: Q1 2026 in Review

Daymark Wealth Partners increased its Boston Scientific (BSX) stake by 67% in Q1 2026, buying an estimated $305K and bringing the position to 9,498 shares worth $596K. The position accounts for 0.02% of the portfolio, ranked #376.

Daymark Wealth Partners first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Daymark Wealth Partners held 9,498 shares of Boston Scientific worth $596K as of Q1 2026.
Daymark Wealth Partners bought 3,810 Boston Scientific shares in Q1 2026, an estimated $305K.
Boston Scientific made up 0.02% of Daymark Wealth Partners's portfolio in Q1 2026, its #376 holding.
Daymark Wealth Partners first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.